Methods and compositions comprising tyrosine kinase inhibitor and triptolide for the treatment of cancer

Provided herein, inter alia, are methods, compositions and kits for treating cancer in a subject. The methods include administration of one or more tyrosine kinase inhibitors and triptolide or an analog thereof to the subject. The methods, compositions and kits are effective for preventing resistanc...

Full description

Saved in:
Bibliographic Details
Main Authors Zheng, Li, Shen, Binghui, Reckamp, Karen, Salgia, Ravi
Format Patent
LanguageEnglish
Published 13.06.2023
Subjects
Online AccessGet full text

Cover

More Information
Summary:Provided herein, inter alia, are methods, compositions and kits for treating cancer in a subject. The methods include administration of one or more tyrosine kinase inhibitors and triptolide or an analog thereof to the subject. The methods, compositions and kits are effective for preventing resistance and/or increasing sensitivity to tyrosine kinase inhibitors.
Bibliography:Application Number: US202117225970